Topiramate
Product Images NDC 80425-0202

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

FDA Label Image

Label 1 (Lable 1)

This is a label of a package of Topiramate 100mg tablets. It contains 30 tablets and the lot number is 30TOP 100623. The expiration date is on June 30, 2023.*

FDA Label Image

Fig 1 (Fig 1)

This is a graph displaying the cumulative rates for time to first seizure in patients treated with Topiramate at two different doses (50 mg/day and 400 mg/day) over time (in days). The graph has different time intervals on the x-axis, and the y-axis shows the cumulative rate of seizures. The graph suggests that patients treated with Topiramate at 400 mg/day have lower cumulative rates of seizures compared to patients treated with 50 mg/day, and the effect increases with time.*

FDA Label Image

Fig 2 (Fig 2)

This is a study on the effectiveness of topiramate. Different doses were given to a varying number of participants over a period of time. The study reports the change from baseline to double-blind phase in the average monthly rate. P-values were also reported.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.